MANHATTAN, Kan. — Two hours west of Kansas City, a multibillion-dollar research hub is emerging on the prairie as a new first line of defense against animal diseases that can decimate livestock, rattle financial markets and potentiallyamp up production of vaccines and other medical countermeasures — and pulling more of that work back to the U.S. from overseas.
Scientists there study nearly three dozen different plant and animal diseases, including wheat blast, swine influenza and Rift Valley fever, as well as food safety.vaccine, which was developed for Zika virus, and has been studying the avian influenza virus fueling the current outbreak in cattle across the U.S.of animal health research" in five years, says Jürgen Richt, the director of K-State's Center of Excellence for Emerging and Zoonotic Animal Diseases.
K-State is also looking to stand up a lab for developing customized vaccines for smaller manufacturers that focus on more localized outbreaks. They expect to break ground this fall and to still ultimately hire 500 employees at the Manhattan campus, which will grow to fill the original footprint, Payne says.on June 14 that they will be delisted by the NYSE, but tells Axios it's appealing that decision and is in the process of raising capital or finding a partner to fulfill its Kansas plans.
Pharmaceutical Companies Influenza Pandemic Pharmaceutical Industry Diagnostic Tests Manufacturing Next Generation Vaccines Animals
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: amNewYork - 🏆 336. / 59 Read more »
Source: FoxNews - 🏆 9. / 87 Read more »
Source: amNewYork - 🏆 336. / 59 Read more »
Source: Gothamist - 🏆 456. / 53 Read more »
Source: amNewYork - 🏆 336. / 59 Read more »
Source: amNewYork - 🏆 336. / 59 Read more »